T‐cell‐mediated hypersensitivity to lumacaftor and ivacaftor in cystic fibrosis-Reference-Cited by-同舟云学术

T‐cell‐mediated hypersensitivity to lumacaftor and ivacaftor in cystic fibrosis

Published:2022-06 Issue:6 Volume:33 Page:
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatric Allergy Immunology

Author:

Semic‐Jusufagic Aida¹^ORCID,Ogese Monday O.²,Edwards Christopher³,Wilkinson Mark⁴,Nissenbaum Claire³,Lee Tim³,Pirmohamed Munir²,Naisbitt Dean J.²

Affiliation:

1. Paediatric Allergy Leeds Children's Hospital, Leeds Teaching Hospitals NHS Trust Leeds UK

2. MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology University of Liverpool Liverpool UK

3. Cystic Fibrosis Centre Leeds Children's Hospital, Leeds Teaching Hospitals NHS Trust Leeds UK

4. Dermatology Department Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust Leeds UK

Funder

Biotechnology and Biological Sciences Research Council

Medical Research Council Canada

Publisher

Wiley

Subject

Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pai.13815

Reference7 articles.

1. New concepts of the pathogenesis of cystic fibrosis lung disease

2. Antibiotic allergy in cystic fibrosis

3. Functional Rescue of F508del-CFTR Using Small Molecule Correctors

4. Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4+ T lymphocytes

5. An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous manifestations of cystic fibrosis;Journal of the American Academy of Dermatology;2024-09

2. Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review;American Journal of Clinical Dermatology;2024-05-16

3. Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis;Toxicological Sciences;2024-04-08

4. Successful Desensitization Protocol to Ivacaftor and a Compound of Elexacaftor/Tezacaftor/Ivacaftor in a Delayed Hypersensitivity Reaction Confirmed by Lymphocyte Transformation Test;Journal of Investigational Allergy and Clinical Immunology;2023-11-15

5. Multiple drugs;Reactions Weekly;2022-07